Pre-publication history
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain
-
* Corresponding author: John Thipphawong JThippha@its.jnj.com
BMC Palliative Care 2009, 8:14 doi:10.1186/1472-684X-8-14
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 08 Jan 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 09 Jan 2009 |
| Resubmission - Version 3 | Manuscript | Author's comment | 15 Jan 2009 |
| Reviewer's Report | Stefan Wirz | 14 Feb 2009 | |
| Reviewer's Report | robert barkin | 02 Mar 2009 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 18 Jun 2009 |
| Reviewer's Report | robert barkin | 03 Jul 2009 | |
| Reviewer's Report | Stefan Wirz | 04 Jul 2009 | |
| Resubmission - Version 5 | Manuscript | Author's comment | 03 Aug 2009 |
| Editorial acceptance | 13 Aug 2009 | ||
| Published | 15 Sep 2009 |